ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021
February 24, 2022Catalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021"). -
Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7%
February 24, 2022Catalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021").
Pharma Sources Insight January 2025
